For instance, there was no significant in difference in BALF recovery between smokers and ex-smokers with COPD, but a strong difference in the expression of DC surface markers such as BDCA-1, CD1a and Langerin. This evidence concerns the gene CD1A and chronic obstructive pulmonary disease.